AG-013736 (AXITINIB) FOR THE TREATMENT OF METASTATIC RENAL CELL CANCER
AG-013736 (AXITINIB) FOR THE TREATMENT OF METASTATIC RENAL CELL CANCER
The study is designed to demonstrate that axitinib (AG-013736) is superior to sorafenib in delaying tumor progression in patients with metastatic renal cell cancer.
Inclusion Criteria:
Exclusion Criteria:
Hershey, Pennsylvania 17033-0850, United States
Charleston, South Carolina 29425, United States
Christiansburg, Virginia 24073, United States
Low Moor, Virginia 24457, United States
Roanoke, Virginia 24014, United States
Salem, Virginia 24153, United States
Wytheville, Virginia 24382, United States
Tuzla, 75000, Bosnia and Herzegovina
Sofia, 1756, Bulgaria
Beijing, Beijing Municipality 100021, China
Haidian District, Beijing Municipality 100853, China
Xi'an, Shaanxi 710032, China
Shanghai, Shanghai Municipality 200127, China
Hangzhou, Zhejiang 310016, China
Hyderabad, Andhra Pradesh 500024, India
Mexico City, Mexico City 14000, Mexico
Quezon City, Diliman, Philippines
Quezon City, National Capital Region 1113, Philippines
Ryazan, Russian Federation 390026, Russia
Saint Petersburg, 197022, Russia
Ufa, 450054, Russia
Dnipro, 49005, Ukraine
Kharkiv, 61037, Ukraine
Kyiv, 03115, Ukraine
Lviv, 79031, Ukraine